These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1957102)

  • 1. [Treatment of pneumocystosis: preclinical evaluation].
    Girard PM; Brun-Pascaud M; Roux P
    Rev Pneumol Clin; 1991; 47(3):109-14. PubMed ID: 1957102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulfamethoxazole-trimethoprim and sulfadoxine-primethamine against fatal pneumocystosis in SCID mice.
    Furuta T; Ito M; Kuramochi T; Hioki K; Nomura T
    J Protozool; 1991; 38(6):221S-222S. PubMed ID: 1818179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast glucan of Pneumocystis carinii cyst wall: an excellent target for chemotherapy.
    Matsumoto Y; Yamada M; Amagai T
    J Protozool; 1991; 38(6):6S-7S. PubMed ID: 1818205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of propolis in an experimental model of pneumocystosis.
    Oguzkaya-Artan M; Nedret Koc A; Silici S; Ozturk A
    Saudi Med J; 2008 Aug; 29(8):1115-8. PubMed ID: 18690302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy.
    Macy JD; Weir EC; Compton SR; Shlomchik MJ; Brownstein DG
    Comp Med; 2000 Feb; 50(1):49-55. PubMed ID: 10987669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal pneumocystosis: a model for man.
    Ceré N; Polack B
    Vet Res; 1999; 30(1):1-26. PubMed ID: 10081109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiometric method for objectively screening large numbers of compounds against Pneumocystis carinii in vitro.
    Comley JC; Mullin RJ; Wolfe LA; Hanlon MH; Ferone R
    J Protozool; 1991; 38(6):144S-146S. PubMed ID: 1818144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomorphology of experimental pneumocystosis and cytogenesis of the pathogen Pneumocystis carinii].
    Arabiĭskiĭ RA; Semenova LA; Mikhaĭlova MA
    Arkh Patol; 1991; 53(2):33-7. PubMed ID: 2069524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone for Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct monitoring as well as sensitive diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction on sputum samples.
    Oka S; Kitada K; Kohjin T; Nakamura Y; Kimura S; Shimada K
    Mol Cell Probes; 1993 Dec; 7(6):419-24. PubMed ID: 7511788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group.
    Siegel SE; Wolff LJ; Baehner RL; Hammond D
    Am J Dis Child; 1984 Nov; 138(11):1051-4. PubMed ID: 6388315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in AIDS.
    Jeantils V; Nguyen G; Bacle F; Thomas M
    Therapie; 1993; 48(1):70-1. PubMed ID: 8356560
    [No Abstract]   [Full Text] [Related]  

  • 15. Models for evaluating compounds for activity against Pneumocystis carinii.
    Bartlett MS
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):199-201. PubMed ID: 2060530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.
    Walzer PD; Kim CK; Foy J; Zhang JL
    Antimicrob Agents Chemother; 1991 Jan; 35(1):158-63. PubMed ID: 2014971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.
    Kim CK; Foy JM; Cushion MT; Stanforth D; Linke MJ; Hendrix HL; Walzer PD
    Antimicrob Agents Chemother; 1987 Feb; 31(2):197-201. PubMed ID: 3494426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.
    Walzer PD; Foy J; Runck J; Steele P; White M; Klein RS; Otter BA; Sundberg RJ
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2572-6. PubMed ID: 7872750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on the development of pneumocystosis in rats.
    Azab ME; Abdel-Mawla MM
    J Egypt Soc Parasitol; 1989 Jun; 19(1):107-13. PubMed ID: 2785148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of water-soluble echinocandin compounds on Pneumocystis pneumonia in mice.
    Furuta T; Muramatsu H; Fujie A; Fujihira S; Abudullah NR; Kojima S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):37-9. PubMed ID: 9449257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.